Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al

Panelists and authors of APCCC

doi:10.1093/annonc/mdv360

Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al

Panelists and authors of APCCC

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2354–2355
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	26
Issue number	11
DOIs	https://doi.org/10.1093/annonc/mdv360
Publication status	Published - Nov 2015

Keywords

Adenocarcinoma/therapy
Androgen Antagonists/therapeutic use
Antineoplastic Agents, Hormonal/therapeutic use
Bone Density Conservation Agents/therapeutic use
Humans
Male
Prostatic Neoplasms/therapy
Prostatic Neoplasms, Castration-Resistant/therapy
Taxoids/therapeutic use

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdv360

Cite this

Panelists and authors of APCCC (2015). Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al. Annals of oncology : official journal of the European Society for Medical Oncology, 26(11), 2354–2355. https://doi.org/10.1093/annonc/mdv360

@article{fc1bfa00fbc6457d8c3cd32ae87e07ca,

title = "Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al",

keywords = "Adenocarcinoma/therapy, Androgen Antagonists/therapeutic use, Antineoplastic Agents, Hormonal/therapeutic use, Bone Density Conservation Agents/therapeutic use, Humans, Male, Prostatic Neoplasms/therapy, Prostatic Neoplasms, Castration-Resistant/therapy, Taxoids/therapeutic use",

author = "{Panelists and authors of APCCC} and S Gillessen and S Fanti and A Omlin",

year = "2015",

month = nov,

doi = "10.1093/annonc/mdv360",

language = "English",

volume = "26",

pages = "2354–2355",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "11",

}

Panelists and authors of APCCC 2015, 'Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 26, no. 11, pp. 2354–2355. https://doi.org/10.1093/annonc/mdv360

Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al. / Panelists and authors of APCCC.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 26, No. 11, 11.2015, p. 2354–2355.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Reply to the letter to the editor 'management of patients with advanced prostate cancer

T2 - recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al

AU - Panelists and authors of APCCC

AU - Gillessen, S

AU - Fanti, S

AU - Omlin, A

PY - 2015/11

Y1 - 2015/11

KW - Adenocarcinoma/therapy

KW - Androgen Antagonists/therapeutic use

KW - Antineoplastic Agents, Hormonal/therapeutic use

KW - Bone Density Conservation Agents/therapeutic use

KW - Humans

KW - Male

KW - Prostatic Neoplasms/therapy

KW - Prostatic Neoplasms, Castration-Resistant/therapy

KW - Taxoids/therapeutic use

U2 - 10.1093/annonc/mdv360

DO - 10.1093/annonc/mdv360

M3 - Article

C2 - 26347101

SN - 0923-7534

VL - 26

SP - 2354

EP - 2355

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

IS - 11

ER -

Panelists and authors of APCCC. Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Nov;26(11):2354–2355. doi: 10.1093/annonc/mdv360